Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yooyoung Pharmaceutical is a South Korean pharmaceutical company founded in 1981 that specializes in the development, manufacturing, and commercialization of therapeutic products across various medical fields. The company's Bio Research Institute, located in Seoul, serves as its primary R&D hub, focusing on the development of innovative biologics, including monoclonal antibodies and recombinant proteins. Yooyoung is a market leader in South Korea for orthopedic treatments, particularly hyaluronic acid-based injections for osteoarthritis like Artz. Beyond orthopedics, the company maintains a diverse pipeline targeting oncology, pain management, and cardiovascular diseases. With GMP-certified manufacturing facilities, Yooyoung provides both proprietary drugs and high-quality generics to the global healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yooyoung Pharmaceuticals Bio Research Institute.